NEW YORK (GenomeWeb) – The GenomeWeb Index dropped around 11 percent in January following declines for the broader stock market, with only one firm in the Index seeing a rise in its stock price.

The decline for the GenomeWeb Index was steeper than the drop for the Dow Jones Industrial Average — which lost nearly 6 percent during the month — and the Nasdaq — which fell nearly 8 percent. But it fared better than the Nasdaq Biotechnology Index, which finished the month 21 percent lower.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.